Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example-Reference-Cited by-同舟云学术

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

Published:2009-01-17 Issue:1 Volume:9 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Beran Jiří,Wertzova Veronika,Honegr Karel,Kaliskova Eva,Havlickova Martina,Havlik Jiří,Jirincova Helena,Van Belle Pascale,Jain Varsha,Innis Bruce,Devaster Jeanne-Marie

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/1471-2334-9-2/fulltext.html

Reference40 articles.

1. World Health Organization (WHO): Influenza vaccines. Wkly Epidemiol Rec. 2005, 80: 279-287.

2. Advisory Committee on immunization Practices (ACIP): Recommendations of the Advisory Committee on immunization Practices (ACIP). Prevention and control of influenza. Morbidity and Mortality Weekly Report. 2008, 57 (RR-7):

3. Demicheli V, Rivetti D, Deeks JJ, Jefferson TO: Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2004, CD001269-3

4. Rose GW, Cooper CL: Fluarix™, inactivated split-virus influenza vaccine. Expert Opin Biol Ther. 2006, 6: 301-310. 10.1517/14712598.6.3.301.

5. Lin YP, Gregory V, Bennett M, Hay A: Recent changes among human influenza viruses. Virus Res. 2004, 103: 47-52. 10.1016/j.virusres.2004.02.011.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable;Expert Review of Vaccines;2023-12-12

2. Inactivated and Recombinant Influenza Vaccines;Plotkin's Vaccines;2023

3. Influenza B: Prospects for the Development of Cross-Protective Vaccines;Viruses;2022-06-17

4. FluB-RAM and FluB-RANS: Genome Rearrangement as Safe and Efficacious Live Attenuated Influenza B Virus Vaccines;Vaccines;2021-08-12

5. Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina;Vaccines;2021-04-01